{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:42:18Z","timestamp":1789501338931,"version":"build-2803163510"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI09\/01245"],"award-info":[{"award-number":["PI09\/01245"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI12\/00156"],"award-info":[{"award-number":["PI12\/00156"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/00287"],"award-info":[{"award-number":["PI16\/00287"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ISCIII-Subdirecci\u00f3n General de Evaluaci\u00f3n y Fomento de la Investigaci\u00f3n","award":["SAF2015-68346-P"],"award-info":[{"award-number":["SAF2015-68346-P"]}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006751","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental","doi-asserted-by":"publisher","award":["CIBERSAM P82"],"award-info":[{"award-number":["CIBERSAM P82"]}],"id":[{"id":"10.13039\/501100006751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006751","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental","doi-asserted-by":"publisher","award":["11INT3"],"award-info":[{"award-number":["11INT3"]}],"id":[{"id":"10.13039\/501100006751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2014 SGR798"],"award-info":[{"award-number":["2014 SGR798"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"IDIBAPS"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.neuropharm.2017.11.049","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T09:18:37Z","timestamp":1512551917000},"page":"219-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["The serotonin hallucinogen 5-MeO-DMT alters cortico-thalamic activity in freely moving mice: Regionally-selective involvement of 5-HT1A and 5-HT2A receptors"],"prefix":"10.1016","volume":"142","author":[{"given":"Maurizio S.","family":"Riga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laia","family":"Llad\u00f3-Pelfort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Artigas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3893-9000","authenticated-orcid":false,"given":"Pau","family":"Celada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.11.049_bib1","first-page":"115","article-title":"Qeeg studies of the acute effects of the visionary tryptamine DMT","volume":"11","author":"Acosta-Urquidi","year":"2015","journal-title":"Cosmos History-the J. Nat. Soc. Philos."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv039","article-title":"Serotonergic psychedelics temporarily modify information transfer in humans","volume":"18","author":"Alonso","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/cercor\/bhg128","article-title":"Co-expression and in\u00a0vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex","volume":"14","author":"Amargos-Bosch","year":"2004","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib4","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.biopsych.2005.02.021","article-title":"Activity and connectivity of brain mood regulating circuit in depression: a functional magnetic resonance study","volume":"57","author":"Anand","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib5","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/sj.npp.1300725","article-title":"Antidepressant effect on connectivity of the mood-regulating circuit: an FMRI study","volume":"30","author":"Anand","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0306-4522(91)90128-B","article-title":"5-Hydroxytryptamine2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex","volume":"40","author":"Araneda","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib7","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1001\/archneurol.2010.35","article-title":"Serotonin 2A receptors and visual hallucinations in Parkinson disease","volume":"67","author":"Ballanger","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/2045125314527985","article-title":"Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles","volume":"4","author":"Baumeister","year":"2014","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib9","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1017\/S146114571000009X","article-title":"Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT(1A) receptors but not 5-HT(2A) receptors","volume":"13","author":"Bortolozzi","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib10","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1126\/science.1099745","article-title":"Neuronal oscillations in cortical networks","volume":"304","author":"Buzsaki","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib11","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1037\/0033-2909.132.2.180","article-title":"Meditation states and traits: EEG, ERP, and neuroimaging studies","volume":"132","author":"Cahn","year":"2006","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib12","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib13","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1073\/pnas.1119598109","article-title":"Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin","volume":"109","author":"Carhart-Harris","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib14","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1073\/pnas.1518377113","article-title":"Neural correlates of the LSD experience revealed by multimodal neuroimaging","volume":"113","author":"Carhart-Harris","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib15","first-page":"1780","article-title":"On visual hallucinations and cortical networks: a trans-diagnostic review","volume":"262","author":"Carter","year":"2015","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib16","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.biopsych.2008.03.013","article-title":"The hallucinogen DOI reduces low-frequency oscillations in rat prefrontal cortex: reversal by antipsychotic drugs","volume":"64","author":"Celada","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib17","doi-asserted-by":"crossref","first-page":"19878","DOI":"10.1073\/pnas.0609440103","article-title":"Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia","volume":"103","author":"Cho","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib18","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/j.biopsych.2016.02.032","article-title":"Intrinsic local beta oscillations in the subgenual cingulate relate to depressive symptoms in treatment-resistant depression","volume":"80","author":"Clark","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib19","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/hbm.21381","article-title":"Seeing with the eyes shut: neural basis of enhanced imagery following Ayahuasca ingestion","volume":"33","author":"de Araujo","year":"2012","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib20","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0028-3908(77)90142-3","article-title":"Preferential action of 5-methoxytryptamine and 5-methoxydimethyltryptamine on presynaptic serotonin receptors - comparative iontophoretic study with LSD and serotonin","volume":"16","author":"Demontigny","year":"1977","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib21","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.1523\/JNEUROSCI.13-10-04316.1993","article-title":"Autoradiographic localization of serotonin receptor subtypes in cat visual cortex: transient regional, laminar, and columnar distributions during postnatal development","volume":"13","author":"Dyck","year":"1993","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib22","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/3738","article-title":"The anatomy of conscious vision: an fMRI study of visual hallucinations","volume":"1","author":"Ffytche","year":"1998","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib23","doi-asserted-by":"crossref","first-page":"G877","DOI":"10.1152\/ajpgi.00435.2001","article-title":"5-HT(2A) receptors: location and functional analysis in intestines of wild-type and 5-HT(2A) knockout mice","volume":"282","author":"Fiorica-Howells","year":"2002","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib24","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Franklin","year":"2008"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0014-2999(72)90073-8","article-title":"Effects of 5-methoxy-N,N-dimethyltryptamine on central monoamine neurons","volume":"19","author":"Fuxe","year":"1972","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/cne.20738","article-title":"Prefrontal cortex in the rat: projections to subcortical autonomic, motor, and limbic centers","volume":"492","author":"Gabbott","year":"2005","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.neuroimage.2008.02.044","article-title":"Multimodal imaging of human early visual cortex by combining functional and molecular measurements with fMRI and PET","volume":"41","author":"Gerstl","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib28","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tips.2008.06.006","article-title":"Serotonin research: contributions to understanding psychoses","volume":"29","author":"Geyer","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature06612","article-title":"Identification of a serotonin\/glutamate receptor complex implicated in psychosis","volume":"452","author":"Gonzalez-Maeso","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib30","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","article-title":"Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior","volume":"53","author":"Gonzalez-Maeso","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib31","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.biopsych.2006.05.046","article-title":"Alterations in medial prefrontal cortical activity and plasticity in rats with disruption of cortical development","volume":"60","author":"Goto","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0079-6123(00)26003-2","article-title":"The prefrontal cortex and the integration of sensory, limbic and autonomic information","volume":"126","author":"Groenewegen","year":"2000","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib33","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1177\/0269881110388326","article-title":"Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice","volume":"25","author":"Halberstadt","year":"2011","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib34","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/1073858405277450","article-title":"Thalamic mechanisms of EEG alpha rhythms and their pathological implications","volume":"11","author":"Hughes","year":"2005","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib35","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/npp.2011.249","article-title":"Clozapine reverses phencyclidine-induced desynchronization of prefrontal cortex through a 5-HT(1A) receptor-dependent mechanism","volume":"37","author":"Kargieman","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib36","doi-asserted-by":"crossref","first-page":"14843","DOI":"10.1073\/pnas.0704848104","article-title":"Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine","volume":"104","author":"Kargieman","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.schres.2011.06.003","article-title":"Frontal areas contribute to reduced global coordination of resting-state gamma activities in drug-naive patients with schizophrenia","volume":"130","author":"Kikuchi","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib38","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.biopsych.2010.10.002","article-title":"The 5-HT2A\/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations","volume":"69","author":"Kometer","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib39","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1007\/s00213-015-4026-7","article-title":"Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations","volume":"232","author":"Kometer","year":"2015","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib40","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00213-006-0566-1","article-title":"The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats","volume":"189","author":"Krebs-Thomson","year":"2006","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib41","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0301-0082(97)00070-1","article-title":"An ultrastructural study of the neural circuit between the prefrontal cortex and the mediodorsal nucleus of the thalamus","volume":"54","author":"Kuroda","year":"1998","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib42","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jpsychires.2016.10.002","article-title":"Escitalopram but not placebo modulates brain rhythmic oscillatory activity in the first week of treatment of Major Depressive Disorder","volume":"84","author":"Leuchter","year":"2017","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib43","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/cercor\/bhr220","article-title":"5-HT1A receptor agonists enhance pyramidal cell firing in prefrontal cortex through a preferential action on GABA interneurons","volume":"22","author":"Llado-Pelfort","year":"2012","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib44","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.euroneuro.2015.11.015","article-title":"Phencyclidine-induced disruption of oscillatory activity in prefrontal cortex: effects of antipsychotic drugs and receptor ligands","volume":"26","author":"Llado-Pelfort","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pharmthera.2004.03.002","article-title":"Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges","volume":"102","author":"McKenna","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib46","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1523\/JNEUROSCI.09-10-03482.1989","article-title":"Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R-(-)2,5-dimethoxy-4-iodo-phenylisopropylamine and 3H-ketanserin","volume":"9","author":"McKenna","year":"1989","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0028-3908(90)90001-8","article-title":"Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes","volume":"29","author":"McKenna","year":"1990","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib48","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/j.celrep.2017.08.002","article-title":"Synaptic regulation of a thalamocortical circuit controls depression-related behavior","volume":"20","author":"Miller","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib49","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.conb.2014.12.004","article-title":"Antidepressant actions of ketamine: from molecular mechanisms to clinical practice","volume":"30","author":"Monteggia","year":"2015","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib50","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/cercor\/bhp114","article-title":"Serotoninergic fine-tuning of the excitation-inhibition balance in rat visual cortical networks","volume":"20","author":"Moreau","year":"2010","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib51","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s002130100703","article-title":"Distinct temporal pattern of the effects of the combined serotonin-reuptake inhibitor and 5-HT1A agonist EMD 68843 on the sleep EEG in healthy men","volume":"155","author":"Murck","year":"2001","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib52","doi-asserted-by":"crossref","first-page":"15171","DOI":"10.1523\/JNEUROSCI.2063-13.2013","article-title":"Broadband cortical desynchronization underlies the human psychedelic state","volume":"33","author":"Muthukumaraswamy","year":"2013","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib53","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","article-title":"Hallucinogens","volume":"101","author":"Nichols","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib54","doi-asserted-by":"crossref","first-page":"e0118143","DOI":"10.1371\/journal.pone.0118143","article-title":"The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network","volume":"10","author":"Palhano-Fontes","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib55","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1523\/JNEUROSCI.12-02-00440.1992","article-title":"Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding","volume":"12","author":"Pompeiano","year":"1992","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib56","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0169-328X(94)90223-2","article-title":"Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors","volume":"23","author":"Pompeiano","year":"1994","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cercor\/bhh104","article-title":"Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in\u00a0vivo: involvement of serotonin and GABA","volume":"15","author":"Puig","year":"2005","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib58","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1021\/cn500350e","article-title":"Serotonin modulation of prefronto-hippocampal rhythms in health and disease","volume":"6","author":"Puig","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib59","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1073\/pnas.98.2.676","article-title":"A\u00a0default mode of brain function","volume":"98","author":"Raichle","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib60","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF01129339","article-title":"Probability mapping: power and coherence analyses of cognitive processes","volume":"1","author":"Rappelsberger","year":"1988","journal-title":"Brain Topogr."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib61","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000077946","article-title":"Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography","volume":"50","author":"Riba","year":"2004","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib62","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1046\/j.1365-2125.2002.01609.x","article-title":"Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers","volume":"53","author":"Riba","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib63","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.neuropharm.2015.10.016","article-title":"The serotonergic hallucinogen 5-methoxy-N,N-dimethyltryptamine disrupts cortical activity in a regionally-selective manner via 5-HT(1A) and 5-HT(2A) receptors","volume":"101","author":"Riga","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib64","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1017\/S1461145714000261","article-title":"The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs","volume":"17","author":"Riga","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib65","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/JCP.0000000000000436","article-title":"Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a SPECT study","volume":"36","author":"Sanches","year":"2016","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib66","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/cercor\/bhh070","article-title":"Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex","volume":"14","author":"Santana","year":"2004","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib67","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.1073\/pnas.95.12.7092","article-title":"Synchronization between prefrontal and posterior association cortex during human working memory","volume":"95","author":"Sarnthein","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib68","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1007\/s00726-011-1078-9","article-title":"Serotonin and molecular neuroimaging in humans using PET","volume":"42","author":"Saulin","year":"2012","journal-title":"Amino Acids"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib69","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0304-3940(96)12607-0","article-title":"The 5-HT1A agonist ipsapirone enhances EEG slow wave activity in human sleep and produces a power spectrum similar to 5-HT2 blockade","volume":"209","author":"Seifritz","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib70","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2174\/138920010794233495","article-title":"Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions","volume":"11","author":"Shen","year":"2010","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib71","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1124\/dmd.111.039107","article-title":"Nonlinear pharmacokinetics of 5-methoxy-N,N-dimethyltryptamine in mice","volume":"39","author":"Shen","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib72","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0022-3565(25)21645-7","article-title":"Determination of selective and nonselective compounds for the 5-HT 1A and 5-HT 1B receptor subtypes in rat frontal cortex","volume":"231","author":"Sills","year":"1984","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib73","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.neuroscience.2005.10.029","article-title":"Grouping of brain rhythms in corticothalamic systems","volume":"137","author":"Steriade","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib74","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.cub.2016.02.010","article-title":"Increased global functional connectivity correlates with LSD-induced ego dissolution","volume":"26","author":"Tagliazucchi","year":"2016","journal-title":"Curr. Biol."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib75","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2869.1993.tb00070.x","article-title":"Effects of ipsapirone, a 5-HT1A agonist, on sleep\/wakefulness cycles: probable post-synaptic action","volume":"2","author":"Tissier","year":"1993","journal-title":"J.\u00a0Sleep. Res."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib76","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0014-2999(85)90467-4","article-title":"Subtypes of the 5-HT receptor mediating the behavioural responses to 5-methoxy-N,N-dimethyltryptamine in the rat","volume":"117","author":"Tricklebank","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib77","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nrn2774","article-title":"Abnormal neural oscillations and synchrony in schizophrenia","volume":"11","author":"Uhlhaas","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib78","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.euroneuro.2016.03.012","article-title":"Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans","volume":"26","author":"Valle","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib79","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.neuropharm.2011.04.001","article-title":"Enhanced effects of amphetamine but reduced effects of the hallucinogen, 5-MeO-DMT, on locomotor activity in 5-HT(1A) receptor knockout mice: implications for schizophrenia","volume":"61","author":"van den Buuse","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib80","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrn2884","article-title":"The neurobiology of psychedelic drugs: implications for the treatment of mood disorders","volume":"11","author":"Vollenweider","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib81","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0893-133X(96)00246-1","article-title":"Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis","volume":"16","author":"Vollenweider","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib82","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","article-title":"Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action","volume":"9","author":"Vollenweider","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib83","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1093\/cercor\/bhn219","article-title":"Enriched expression of serotonin 1B and 2A receptor genes in macaque visual cortex and their bidirectional modulatory effects on neuronal responses","volume":"19","author":"Watakabe","year":"2009","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2017.11.049_bib84","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1073\/pnas.1700756114","article-title":"Rhythmic brain stimulation reduces anxiety-related behavior in a mouse model based on meditation training","volume":"114","author":"Weible","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib85","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0091-3057(99)00178-1","article-title":"The paradox of 5-methoxy-N,N-dimethyltryptamine: an indoleamine hallucinogen that induces stimulus control via 5-HT1A receptors","volume":"65","author":"Winter","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib86","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1523\/JNEUROSCI.6377-11.2012","article-title":"Disruption of prefrontal cortex large scale neuronal activity by different classes of psychotomimetic drugs","volume":"32","author":"Wood","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.11.049_bib87","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A\u00a0randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817305889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817305889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T05:31:37Z","timestamp":1751088697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817305889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":87,"alternative-id":["S0028390817305889"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.11.049","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The serotonin hallucinogen 5-MeO-DMT alters cortico-thalamic activity in freely moving mice: Regionally-selective involvement of 5-HT1A and 5-HT2A receptors","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.11.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}